Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

NCT01490723 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

DRUG: Rituximab
DRUG: 111In Ibritumomab
PROCEDURE: Planar Scintigraphy Imaging
DRUG: 90Y IbritumomabTiuxetan
DRUG: Fludarabine
DRUG: Bendamustine
DRUG: Thymoglobulin
DRUG: Tacrolimus
DRUG: Methotrexate
DRUG: Mycophenolate
DRUG: G-CSF
PROCEDURE: Stem Cell Transplantation

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]